FXN and cancer: Furthermore, a significant number of genes included in the Ingenuity biological function category of Cancer (104 and 475 genes in Cancer and its subcategories, p≤0.05, for FRDA children and FRDA adults, respectively; data not shown) may explain the malignant transformation potential of frataxin-deficient cells, both in vitro and in vivo[10],[48],[52].